MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.280
-0.200 (-5.75%)
At close: Nov 20, 2024, 4:00 PM
3.260
-0.020 (-0.61%)
After-hours: Nov 20, 2024, 7:31 PM EST

MacroGenics Revenue

MacroGenics had revenue of $110.71M in the quarter ending September 30, 2024, with 964.81% growth. This brings the company's revenue in the last twelve months to $141.33M, up 16.68% year-over-year. In the year 2023, MacroGenics had annual revenue of $58.75M, down -61.33%.

Revenue (ttm)
$141.33M
Revenue Growth
+16.68%
P/S Ratio
1.45
Revenue / Employee
$416,900
Employees
339
Market Cap
205.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202358.75M-93.19M-61.33%
Dec 31, 2022151.94M74.49M96.19%
Dec 31, 202177.45M-27.44M-26.16%
Dec 31, 2020104.88M40.70M63.40%
Dec 31, 201964.19M4.07M6.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 193.06M
Personalis 87.49M
Genfit 86.23M
SOPHiA GENETICS 64.49M
Utah Medical Products 44.08M
Zentalis Pharmaceuticals 40.56M
Molecular Partners AG 7.11M
Sera Prognostics 94.00K
Revenue Rankings